Meptazinol Hydrochloride (CAS 59263-76-2): A Comprehensive Guide

Explore the unique properties, applications, and market insights of Meptazinol Hydrochloride, a key pharmaceutical intermediate and analgesic agent. Discover its role in pain management and neurochemical research.

Get a Quote & Sample

Advantages of Meptazinol Hydrochloride

Selective Mu-1 Opioid Receptor Activity

Meptazinol Hydrochloride exhibits a relative selectivity for mu-1 opioid receptor sites, potentially leading to a reduced incidence of side effects associated with traditional opioid analgesics.

Dual Pharmacological Action

Its combined activity as an opioid analgesic and an acetylcholinesterase inhibitor broadens its potential applications in pain management and neurological research, offering unique Meptazinol Hydrochloride properties.

Reliable Pharmaceutical Intermediate

As a high-quality Meptazinol Hydrochloride pharmaceutical intermediate, it supports robust drug discovery and development processes, contributing to advancements in therapeutic solutions.

Key Applications

Pain Management

Meptazinol Hydrochloride is indicated for the treatment of moderate to severe pain, including post-operative pain, obstetric pain, and renal colic, showcasing its effectiveness in clinical settings.

Neurochemical Research

Its acetylcholinesterase inhibitory properties make it a valuable tool for researchers studying neurological pathways and developing treatments for conditions like Alzheimer's disease.

Pharmaceutical Synthesis

As a crucial pharmaceutical intermediate, it aids in the synthesis of novel drug candidates and complex molecules, facilitating innovation in the pharmaceutical industry.

Drug Discovery Studies

Researchers utilize Meptazinol Hydrochloride in drug discovery studies to explore novel analgesic mechanisms and understand opioid receptor interactions, leveraging its unique Meptazinol Hydrochloride properties.